A regulation from the Centers for Medicare and Medicaid Services (CMS) required that, starting January 1, 2021, all U.S. hospitals publicly display the cash price as well as the minimum and maximum negotiated charge for 300 “shoppable services.”
Vivian Ho, Alan Beltran Lara, David Ruiz, Peter Cram, M.D., Marah ShortMay 12, 2022
The authors articulate an approach for reducing COVID-19 vaccine inequity through globally distributed manufacturing of vaccines. Read the commentary published in The Lancet.
A study found that private equity acquisition of hospitals had no substantial association with the patient-level outcomes examined,
although it was associated with a moderate improvement in mortality among Medicare beneficiaries hospitalized with acute myocardial infarction.
A study of U.S. hospitals acquired by private equity firms found improved financial performance — and that patient throughput (or the process of admitting, treating and discharging patients) increased while staffing decreased.
Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).
In a joint letter, a group of scientists calls on U.S. policymakers and the nation's scientific communities to avoid shunning Russian scientists and academics for the actions of Russia's government in light of the invasion of Ukraine.
The intense marketing of unproven stem cell interventions has become an international health concern. The authors offer resources and suggestions for physicians seeking to effectively counsel patients and respond to their questions about various stem cell therapies.